NeoGenomics, Inc(NASDAQ:NEO) 
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates in two segments, Clinical Services and Pharma Services. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceuti...
Website: http://www.neogenomics.com
Founded: 2002
Full Time Employees: 1,700
CEO: Douglas M. Van Oort
Sector: Healthcare
Industry: Diagnostics & Research
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 8.41
H 9.14
L 8.27
C 8.78
V 2,065,610
10EMA 8.78
20EMA 8.78
60EMA 8.78
120EMA 8.78
250EMA 8.78